Found: 26
Select item for more details and to access through your institution.
Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 8, p. 1, doi. 10.1371/journal.pntd.0008637
- By:
- Publication type:
- Article
Natural history of nonhuman primates after conjunctival exposure to Ebola virus.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31027-7
- By:
- Publication type:
- Article
Combination therapy protects macaques against advanced Marburg virus disease.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22132-0
- By:
- Publication type:
- Article
Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus.
- Published in:
- Journal of Infectious Diseases, 2016, v. 214, p. S263, doi. 10.1093/infdis/jiw149
- By:
- Publication type:
- Article
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
- Published in:
- Journal of Clinical Investigation, 2020, v. 130, n. 1, p. 539, doi. 10.1172/JCI131958
- By:
- Publication type:
- Article
siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.
- Published in:
- Pathogens, 2023, v. 12, n. 12, p. 1408, doi. 10.3390/pathogens12121408
- By:
- Publication type:
- Article
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic.
- Published in:
- Pathogens, 2022, v. 11, n. 6, p. 655, doi. 10.3390/pathogens11060655
- By:
- Publication type:
- Article
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 384, p. 1, doi. 10.1126/scitranslmed.aai8711
- By:
- Publication type:
- Article
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase.
- Published in:
- Virology Journal, 2020, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12985-020-01396-w
- By:
- Publication type:
- Article
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 250, p. 1, doi. 10.1126/scitranslmed.3009706
- By:
- Publication type:
- Article
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.
- Published in:
- Nature, 2015, v. 521, n. 7552, p. 362, doi. 10.1038/nature14442
- By:
- Publication type:
- Article
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adl2055
- By:
- Publication type:
- Article
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S701, doi. 10.1093/infdis/jiad278
- By:
- Publication type:
- Article
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S660, doi. 10.1093/infdis/jiad157
- By:
- Publication type:
- Article
Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S571, doi. 10.1093/infdis/jiad225
- By:
- Publication type:
- Article
A Recombinant Vesicular Stomatitis Virus–Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S712, doi. 10.1093/infdis/jiad207
- By:
- Publication type:
- Article
Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S604, doi. 10.1093/infdis/jiad137
- By:
- Publication type:
- Article
Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17446-4
- By:
- Publication type:
- Article
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
- Published in:
- PLoS Neglected Tropical Diseases, 2022, v. 16, n. 5, p. 1, doi. 10.1371/journal.pntd.0010433
- By:
- Publication type:
- Article